- US-listed companies
- Nemaura Medical Inc.
- Income statement
Nemaura Medical Inc. (NMRD) Income statement
Market cap
$5.78K
P/E ratio
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | |
| Revenue | - | - | - | - | - | - | - | 503,906 | 77,044 |
| Revenue growth (%) | - | - | - | - | - | - | - | - | |
| Cost of revenue | - | - | - | - | - | - | - | 344,300 | 75,328 |
| Gross profit | - | - | - | - | - | - | - | 159,606 | -1,476,392 |
| Gross margin (%) | - | - | - | - | - | - | - | ||
| Research & development | 824,503 | 1 | 1 | 993,833 | 2 | 2 | 2 | 2 | 2 |
| Operating margin (%) | - | - | - | - | - | - | - | ||
| Operating expenses | 1 | 2 | 2 | 2 | 4 | 5 | 5 | 8 | 8 |
| Operating income | -1,319,840 | -1,539,637 | -1,551,266 | -1,908,965 | -4,476,724 | -4,778,484 | -4,586,741 | -7,570,431 | -9,595,234 |
| Income before tax | - | - | - | - | - | -4,774,558 | -6,594,428 | -14,237,061 | -14,143,735 |
| Pretax margin (%) | - | - | - | - | - | - | - | -2,825.3 | -18,358 |
| Provision for income taxes | - | - | - | - | - | -614,362 | -335,832 | -350,256 | - |
| Effective tax rate (%) | - | - | - | - | - | - | |||
| Net income | -1,319,840 | -1,539,637 | -1,551,266 | -1,820,449 | -4,452,797 | -4,160,196 | -6,258,596 | -13,886,805 | -14,143,735 |
| Net income margin (%) | - | - | - | - | - | - | - | ||
| EBITDA | |||||||||
| EBITDA margin (%) | - | - | - | - | - | - | - |